Skip to main content
Article
Licensed
Unlicensed Requires Authentication

Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells

  • and EMAIL logo
Published/Copyright: August 20, 2015

Abstract

Recent studies have demonstrated that acquisition of epithelial-mesenchymal transition (EMT) is associated with drug resistance in lung cancer cells. However, the underlying mechanisms are not fully elucidated. Emerging evidence suggests that microRNAs play a crucial role in controlling EMT. The aim of this study was to explore the potential role of miR-125b in governing EMT in paclitaxel-resistant (PR) lung cancer cells. To achieve this goal, we explored the role of miR-125b in regulation of EMT in stable PR lung cancer cells, namely A549-PR and H460-PR. We found that miR-125b was significantly downregulated in A549-PR and H460-PR cells. Notably, ectopic expression of miR-125b led to the reversal of EMT phenotype. Moreover, we found that miR-125b governed PR-induced EMT partly due to down-regulation of its target Sema4C. More importantly, overexpression of miR-125b or depletion of Sema4C sensitized PR cells to paclitaxel. Furthermore, stable overexpression miR-125b in A549-PR cells inhibited tumor xenograft growth in immunodeficient mice. Our study implied that up-regulation of miR-125b could be a novel approach to reverse chemotherapy resistance in lung cancers.

Received: 2015-8-10
Accepted: 2015-8-15
Published Online: 2015-8-20

© 2015 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. Retraction Note to the article: “EDD1 predicts prognosis and regulates gastric cancer growth in vitro and in vivo via miR-22“
  2. EDD1 predicts prognosis and regulates gastric cancer growth in vitro and in vivo via miR-22
  3. Retraction Note to the article “Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells
  4. Up-regulation of miR-125b reverses epithelial-mesenchymal transition in paclitaxel-resistant lung cancer cells
  5. Adherens junctions balance stability and motility: from cell morphogenesis to neural tissue patterning
  6. Glue it together: self-assembly of the antibacterial GTPase GBP1
  7. Inhibition of Aβ(40) peptide aggregation by Milk-derived Amyloid-like Protein Aggregates (MAPA)
  8. Mechanistic insights into Ras-catalyzed GTP hydrolysis: conformational dynamics, catalytic mechanisms, and emerging therapeutic strategies
  9. Sarcomere analysis in human cardiomyocytes by computing radial frequency spectra
  10. The role of PDE6D in trafficking KRAS
  11. Molecular mechanisms shaping the actin filament scaffold of dendritic filopodia
  12. CCM scaffolds at the frontier of biomechanics: their roles in vascular physiology and disease
  13. CNKSR2 scaffold function in the mammalian nervous system
  14. Endocytic scaffolds at the crossroads of Alzheimer’s disease and neuronal aging
  15. Albrecht Kossel and the nucleobases – a review of his life and work
  16. Intersectins as versatile scaffolds for membrane-associated processes
  17. Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancer
  18. GAP mimetic activity of pan-Ras TCI daraxonrasib synergizes with K-Ras Switch-II pocket inhibition
  19. Posttranslational modifications of RAS: few pockets but many bumps
  20. The heart of the matter: a personal view of Fred Wittinghofer’s contributions to RAS biology and drug design
  21. Fred Wittinghofer and the GTP/GDP-binding proteins
  22. Felix Hoppe-Seyler (1825–1895): a pioneer in the field of biochemistry with many significant contributions to the development of the discipline
Downloaded on 26.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/hsz-2015-0153/html?lang=en
Scroll to top button